| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $250K | -92.3% |
| R&D Expense | $7.6M | -27.9% |
| SG&A Expense | $8.9M | -22.4% |
| Operating Income | -$19.3M | -2.8% |
| Pre-tax Income | -$14.3M | +19.7% |
| Income Tax | $50K | +0.0% |
| Net Income | -$14.4M | +19.6% |
| EPS (Basic) | -$8.46 | +23.6% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.2M | -39.4% |
| Accounts Receivable | $116K | — |
| Current Assets | $25.8M | -40.5% |
| Total Assets | $25.9M | -44.6% |
| Current Liabilities | $2.3M | -70.8% |
| Total Liabilities | $2.3M | -70.8% |
| Stockholders' Equity | $23.6M | -39.2% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | +1.0% |
| Investing Cash Flow | -$166K | -1409.1% |
| Financing Cash Flow | -$956K | -103.0% |